InvestorsHub Logo
Followers 80
Posts 1038
Boards Moderated 0
Alias Born 06/26/2014

Re: None

Friday, 09/23/2016 5:09:08 PM

Friday, September 23, 2016 5:09:08 PM

Post# of 426700
Thinking out loud in here, opinions are most welcomed

"Roxane Laboratories, Inc. and Dr. Reddy’s Laboratories, Inc., respectively, advising Amarin that such companies have filed abbreviated new drug applications (each, an “ANDA”) with the U.S. Food and Drug Administration (“FDA”) that seek regulatory approval for generic versions of Vascepa ® (icosapent ethyl) capsules."

Have filed with the FDA

Is there a chance that FDA will not consider them received?!

That might explain the surge in the SP
As always there is a leak and once it is official from FDA that it is not received, that will have positive effect on the price

Again, just a thought and your opinions are highly appreciated
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News